On May 14, 2024, AEB CEO Tadzio Schilling spoke at the plenary session of the 31th Russian Pharmaceutical Forum in St. Petersburg.

For 30 years, the forum brings together leading pharmacy and healthcare experts.

The pharmaceutical industry leaders touched upon trends and prospects of the industry development in a new economic environment and shared the views on the issue of patent rights protection, government support measures as well as price regulation.

Tadzio Shilling noted that foreign business now assesses prospects in Russia more stable than in the previous two years and outlined that the dialogue between the state and pharmaceutical manufacturers is still relevant.